These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11668510)

  • 1. Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells.
    Shirakawa T; Sasaki R; Gardner TA; Kao C; Zhang ZJ; Sugimura K; Matsuo M; Kamidono S; Gotoh A
    Int J Cancer; 2001 Oct; 94(2):282-9. PubMed ID: 11668510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
    Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
    Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
    Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
    Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.
    Tsunemitsu Y; Kagawa S; Tokunaga N; Otani S; Umeoka T; Roth JA; Fang B; Tanaka N; Fujiwara T
    Gut; 2004 Apr; 53(4):554-60. PubMed ID: 15016751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
    Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
    Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines.
    Kagawa S; Gu J; Swisher SG; Ji L; Roth JA; Lai D; Stephens LC; Fang B
    Cancer Res; 2000 Mar; 60(5):1157-61. PubMed ID: 10728665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model.
    Shirakawa T; Gotoh A; Gardner TA; Kao C; Zhang ZJ; Matsubara S; Wada Y; Hinata N; Fujisawa M; Hanioka K; Matsuo M; Kamidono S
    J Gene Med; 2000; 2(6):426-32. PubMed ID: 11199263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.
    Hall MC; Li Y; Pong RC; Ely B; Sagalowsky AI; Hsieh JT
    J Urol; 2000 Mar; 163(3):1033-8. PubMed ID: 10688044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
    Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination with CD/5-FC gene therapy enhances killing of human bladder-cancer cells by radiation.
    Zhang Z; Shirakawa T; Hinata N; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Matsuo M; Gotoh A
    J Gene Med; 2003 Oct; 5(10):860-867. PubMed ID: 14533194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells.
    Schumacher G; Bruckheimer EM; Beham AW; Honda T; Brisbay S; Roth JA; Logothetis C; McDonnell TJ
    Int J Cancer; 2001 Jan; 91(2):159-66. PubMed ID: 11146439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Mutation in bladder cancer patients in Japan and inhibition of growth by in vitro adenovirus-mediated wild-type p53 transduction in bladder cancer cells.
    Irie A; Uchida T; Ishida H; Matsumoto K; Iwamura M; Baba S
    Mol Urol; 2001; 5(2):53-8. PubMed ID: 11690548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
    Ruifa H; Liwei L; Binxin L; Ximing L
    Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
    Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
    Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
    Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
    Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
    Seth P; Katayose D; Li Z; Kim M; Wersto R; Craig C; Shanmugam N; Ohri E; Mudahar B; Rakkar AN; Kodali P; Cowan K
    Cancer Gene Ther; 1997; 4(6):383-90. PubMed ID: 9408609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.